Literature DB >> 31473216

Retinal Thickness and Microvascular Changes in Children With Sickle Cell Disease Evaluated by Optical Coherence Tomography (OCT) and OCT Angiography.

Sally S Ong1, Marguerite O Linz1, Ximin Li2, T Y Alvin Liu1, Ian C Han3, Adrienne W Scott4.   

Abstract

PURPOSE: To compare the severity of macular vascular changes in children with sickle cell disease (SCD) vs age- and race-matched controls.
DESIGN: Cross-sectional study.
METHODS: Children (<18 years old) with HbSS and HbS variant (HbSC and HbS thalassemia) genotypes, and their age- and race-matched controls, were recruited between January 2017 and December 2018. All subjects underwent optical coherence tomography angiography (OCTA) scans centered on the fovea and temporal macula. Retinal thickness, superficial capillary plexus (SCP) and deep capillary plexus (DCP) vessel density (VD), and foveal avascular zone (FAZ) size were measured and compared between HbSS and HbS variant vs controls.
RESULTS: Thirty-four HbSS, 34 HbS variant (Goldberg staging 0-3 for SCD eyes), and 24 control eyes (total 48 children, aged 5-17 years) were included. Total VD (3-mm ETDRS circle) was lower in HbS variant eyes than in controls for both the SCP (42.9% vs 47.7%, P = .02) and DCP (47.4% vs 52.6%, P = .01). In HbSS eyes, VD was lower in the DCP (47.7%, P = .008) but not in the SCP (45.5%, P = .5), compared to controls. A higher proportion of HbSS (n = 18, 55%) than HbS variant eyes (n = 9, 26%) had pathologic areas of retinal thinning associated with SCP and DCP flow loss (P = .03). However, retinal thickness measurements and FAZ size did not differ between either HbSS or HbS variant group vs controls.
CONCLUSIONS: Children with SCD have similar retinal thickness but less dense vasculature on OCTA compared to age and race-matched controls, suggesting that microvascular insult may precede structural thinning.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31473216     DOI: 10.1016/j.ajo.2019.08.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Action on sickle cell retinopathy: the time is now.

Authors:  Christiana Dinah; Brigit Greystoke; Isabella Mueller; James Talks
Journal:  Eye (Lond)       Date:  2022-01-28       Impact factor: 4.456

2.  Simultaneous visible light optical coherence tomography and near infrared OCT angiography in retinal pathologies: A case study.

Authors:  Jingyu Wang; Andrew Baker; Manju L Subramanian; Nicole H Siegel; Xuejing Chen; Steven Ness; Ji Yi
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-14

Review 3.  Artificial intelligence for improving sickle cell retinopathy diagnosis and management.

Authors:  Sophie Cai; Ian C Han; Adrienne W Scott
Journal:  Eye (Lond)       Date:  2021-05-06       Impact factor: 4.456

4.  Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.

Authors:  Jing Jin; Vinay Kandula; Robin E Miller
Journal:  Pediatr Blood Cancer       Date:  2021-03-31       Impact factor: 3.838

5.  Conjunctival optical coherence tomography angiography imaging in sickle cell maculopathy.

Authors:  Glory E Mgboji; Dennis Cain; Adrienne W Scott
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-16

6.  Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study.

Authors:  Juliana Prazeres; Luiz Filipe Lucatto; Adriano Ferreira; Nilva Moraes; Josefina A P Braga; Luiz H Lima; Caio Regatieri; Maurício Maia
Journal:  Int J Retina Vitreous       Date:  2022-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.